+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
MALE
ID07287150

Phase II Trial Comparing Inavolisib Plus Enzalutamide to Other Androgen Receptor Inhibitors or Docetaxel in Men With Metastatic Castration-Resistant Prostate Cancer

Led by Hoffmann-La Roche · Updated on 2026-10-08

100

Participants Needed

48

Research Sites

69 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the combination of inavolisib plus enzalutamide compared with a physicians choice of alternative androgen receptor pathway inhibitor or docetaxel in men with metastatic castrate-resistant prostate cancer mCRPC who have previously received one second-generation androgen receptor pathway inhibitor. The study aims to assess the efficacy and safety of these treatments in biomarker-selected participants. This is a phase II, randomized, open-label trial sponsored by Hoffmann-La Roche. Participants in the study will be randomly assigned to receive either the combination of inavolisib and enzalutamide taken orally or a physicians choice of another androgen receptor pathway inhibitor enzalutamide or abiraterone or intravenous docetaxel. Treatments will be administered according to the schedule specified in the study protocol. The trial compares these options to find the best approach for treating mCRPC after prior therapy. During the study, participants will be monitored for radiographic progression-free survival up to approximately 5 years. Researchers will also assess response rates, prostate-specific antigen levels, duration of response, overall survival, and adverse events over this period. The study includes regular evaluations and safety monitoring to understand how well participants respond to the treatments and to track any side effects throughout the trial duration.

CONDITIONS

Brief Title

A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

Research Team

R

Reference Study ID Number: CO45813 https://forpatients.roche.com/ No attachments to email below.

F

Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here